Viread

Gilead forks over $40M to settle thousands of claims in web of litigation over alleged delay of safer HIV meds
Fierce Pharma
Tue, 06/11/24 - 10:46 pm
Gilead Sciences
legal
HUV
Viread
Truvada
Vemlidy
Gilead can't escape antitrust suit centered on pay-for-delay deal with Cipla, judge says
Fierce Pharma
Tue, 08/23/22 - 10:24 pm
Gilead Sciences
Cipla
pay-for-delay
legal generics
Emtriva
Viread
Can Teva Jump-Start Its Restructuring By Swiping Some Of Gilead's Sales?
Investors Business Daily
Sat, 12/16/17 - 08:46 am
Teva Pharmaceutical
restructuring
Gilead Sciences
generics
Viread
Teva rolls out exclusive generic of Gilead's Viread at the end of an awful week
Fierce Pharma
Fri, 12/15/17 - 11:40 pm
Teva Pharmaceutical
Gilead Sciences
Viread
hepatitis B
HIV
antivirals
Top 10 U.S. patent losses of 2017
Fierce Pharma
Thu, 02/23/17 - 09:29 am
patents
Copaxone
Cialis
Viagra
Velcade
Sustiva
Sandostatin LAR
Norditropin
Viread
Pristiq
Strattera
Pfizer
Teva
Takeda
Eli Lilly
Novartis
Bristol-Myers Squibb
Novo Nordisk
Gilead Sciences
Gilead grabs priority review for pangenotype hep C combo; Hep B med shown to be safe
BioPharma Dive
Wed, 01/6/16 - 11:01 am
Gilead Sciences
hepatitis C
hepatitis B
Sovaldi + velpatasvir
Viread
Gilead's Little Tweak Could Produce Big Revenue
Investopedia
Thu, 04/9/15 - 09:42 am
Gilead Sciences
HIV
Viread
TAF
Recent Developments In Gilead's Non-Hepatitis C Programs
Seeking Alpha
Tue, 05/27/14 - 11:55 am
Gilead Sciences
RSV
GS-5806
Viread
TAF
Ranexa
atrial fibrillation
Gilead Settles Teva HIV Drug Patent Suit to Avoid Trial
Bloomberg
Wed, 02/20/13 - 12:05 pm
Teva
patents
HIV
Gilead
Viread
hepatitis B
European Commission approves oral granule formulation of Gilead Viread
Pharmaceutical Business Review
Sat, 12/15/12 - 12:57 pm
Gilead Sciences
Viread
HIV
AIDS
Gilead's Viread new formulations approved by FDA for use by children with HIV
Yahoo/Fly on the Wall
Thu, 01/19/12 - 11:13 am
Viread
Gilread
HIV
FDA
Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Yahoo/BusinessWire
Sat, 11/5/11 - 02:46 pm
Viread
Gilead Sciences
hepatitis B
Gilead gets subpoena from Justice Department
MarketWatch
Sat, 06/11/11 - 10:23 am
Gilead Sciences
Atripla
Emtriva
Hepsera
Letairis
Truvada
Viread
Viread® for Hepatitis B Maintains Antiviral Suppression with No Development of Resistance Through Four Years of Treatment
Yahoo/BusinessWire
Sat, 10/30/10 - 12:22 pm
Viread
Gilead Sciences
hepatitis B
Down to the Bone: Is an HIV Drug's Link to Fractures Underplayed?
BNET Pharma
Tue, 07/20/10 - 08:25 am
Viread
Gilead Sciences
HIV
Gilead-Glaxo Deal Targets Asia
Yahoo/Zacks.com
Thu, 12/3/09 - 09:48 am
Gilead Sciences
Asia
GSK
partnerships
Viread
Bristol-Myers Squibb
Gilead signs sales deal with Glaxo for Viread
Yahoo/AP
Tue, 11/24/09 - 10:20 am
Viread
hepatitis B
GSK
Gilead Sciences
Asia
Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread® For Chronic Hepatitis B
Yahoo/Business Wire
Sun, 11/1/09 - 09:05 am
Viread
Gilead Sciences
hepatitis B
Gilead CEO Sees Sales Gains on Earlier AIDS Treatment
Bloomberg
Fri, 05/29/09 - 03:43 am
Gilead Sciences
AIDS
Atripla
Truvada
Viread